Chemistry, Manufacturing, and Controls Changes to an Approved Application: Certain Biological Products: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 21, 2021
August 27, 2021
27111644-ec6f-4414-997c-1a3ca9f85b8a
Related Documents
Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products: Guidance for Industry
Guidance DocumentDecember 16, 2020Center for Biologics Evaluation and Research
Testing for Biotin Interference in In Vitro Diagnostic Devices: Guidance for Industry
Guidance DocumentOctober 16, 2020Center for Biologics Evaluation and Research
Comparability Protocols for Postapproval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA
Guidance DocumentOctober 13, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox